Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Karuna Therapeutics, Inc.    KRTX

KARUNA THERAPEUTICS, INC.

(KRTX)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in  $ Estimates in  $
Fiscal Period December 2018 2019 (e) 2020 (e) 2021 (e)
Sales - - - -
EBITDA - -48,5 -86,6 -92,0
Operating profit (EBIT) -14,5 -47,5 -69,9 -82,4
Pre-Tax Profit (EBT) - -48,8 -72,6 -84,8
Net income - -48,8 -72,6 -84,8
P/E ratio - -53,5x -36,2x -33,8x
EPS ( $ ) -3,06 -1,96 -2,89 -3,09
Dividend per Share (  ) - - - -
Yield - - - -
Reference price ( $ ) - 104,520 104,520 104,520
Announcement Date 12/31/1969
07:00pm
- - -
Finances - Leverage
Estimates in M $
Fiscal Period December 2019 (e) 2020 (e) 2021 (e)
Debt - - -
Finance 292 255 347
Operating income (EBITDA) -48,5 -86,6 -92,0
Leverage
(Debt/EBITDA)
- - -
Capital Expenditure 0,22 0,59 1,00
Free Cash Flow (FCF) 42,0 -69,0 -79,5
Book Value Per Share (BVPS) (  ) - - -
Cash Flow per Share (  ) - - -
Announcement Date - - -
Balance Sheet Analysis
Assessed data source
© 2020 S&P Global Market Intelligence
Financial Ratios

Size 2019e 2020e
Capitalization 2 719 M $ -
Entreprise Value (EV) 2 427 M $ 2 463 M $
Valuation 2019e 2020e
P/E ratio (Price / EPS) -53,5x -36,2x
Capitalization / Revenue - -
EV / Revenue - -
EV / EBITDA -50,0x -28,0x
Yield (DPS / Price) - -
Price to book (Price / BVPS) - -
Profitability 2019e 2020e
Operating Margin (EBIT / Sales) - -
Operating Leverage (Delta EBIT / Delta Sales) - -
Net Margin (Net Profit / Revenue) - -
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) - -
Rate of Dividend - -
Balance Sheet Analysis 2019e 2020e
CAPEX / Sales   - -
Cash Flow / Sales - -
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) - -
EPS & Dividend